212 related articles for article (PubMed ID: 10023686)
1. Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases.
Rickert P; Corden JL; Lees E
Oncogene; 1999 Jan; 18(4):1093-102. PubMed ID: 10023686
[TBL] [Abstract][Full Text] [Related]
2. Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences.
Ramanathan Y; Rajpara SM; Reza SM; Lees E; Shuman S; Mathews MB; Pe'ery T
J Biol Chem; 2001 Apr; 276(14):10913-20. PubMed ID: 11278802
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activity of positive transcription elongation factor b kinase in vivo requires the C-terminal domain of RNA polymerase II.
Napolitano G; Majello B; Licciardo P; Giordano A; Lania L
Gene; 2000 Aug; 254(1-2):139-45. PubMed ID: 10974544
[TBL] [Abstract][Full Text] [Related]
4. Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II.
Rickert P; Seghezzi W; Shanahan F; Cho H; Lees E
Oncogene; 1996 Jun; 12(12):2631-40. PubMed ID: 8700522
[TBL] [Abstract][Full Text] [Related]
5. TFIIH is negatively regulated by cdk8-containing mediator complexes.
Akoulitchev S; Chuikov S; Reinberg D
Nature; 2000 Sep; 407(6800):102-6. PubMed ID: 10993082
[TBL] [Abstract][Full Text] [Related]
6. Modulation of TFIIH-associated kinase activity by complex formation and its relationship with CTD phosphorylation of RNA polymerase II.
Watanabe Y; Fujimoto H; Watanabe T; Maekawa T; Masutani C; Hanaoka F; Ohkuma Y
Genes Cells; 2000 May; 5(5):407-23. PubMed ID: 10886368
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Tat-associated RNA polymerase C-terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat-mediated transcription.
Nekhai S; Zhou M; Fernandez A; Lane WS; Lamb NJ; Brady J; Kumar A
Biochem J; 2002 Jun; 364(Pt 3):649-57. PubMed ID: 12049628
[TBL] [Abstract][Full Text] [Related]
8. Three cyclin-dependent kinases preferentially phosphorylate different parts of the C-terminal domain of the large subunit of RNA polymerase II.
Pinhero R; Liaw P; Bertens K; Yankulov K
Eur J Biochem; 2004 Mar; 271(5):1004-14. PubMed ID: 15009212
[TBL] [Abstract][Full Text] [Related]
9. Comparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKs.
Guo Z; Stiller JW
BMC Genomics; 2004 Sep; 5():69. PubMed ID: 15380029
[TBL] [Abstract][Full Text] [Related]
10. T-loop phosphorylation stabilizes the CDK7-cyclin H-MAT1 complex in vivo and regulates its CTD kinase activity.
Larochelle S; Chen J; Knights R; Pandur J; Morcillo P; Erdjument-Bromage H; Tempst P; Suter B; Fisher RP
EMBO J; 2001 Jul; 20(14):3749-59. PubMed ID: 11447116
[TBL] [Abstract][Full Text] [Related]
11. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription.
Zhou M; Halanski MA; Radonovich MF; Kashanchi F; Peng J; Price DH; Brady JN
Mol Cell Biol; 2000 Jul; 20(14):5077-86. PubMed ID: 10866664
[TBL] [Abstract][Full Text] [Related]
12. Regulation of CDK7-carboxyl-terminal domain kinase activity by the tumor suppressor p16(INK4A) contributes to cell cycle regulation.
Nishiwaki E; Turner SL; Harju S; Miyazaki S; Kashiwagi M; Koh J; Serizawa H
Mol Cell Biol; 2000 Oct; 20(20):7726-34. PubMed ID: 11003668
[TBL] [Abstract][Full Text] [Related]
13. The cyclin H/cdk7/Mat1 kinase activity is regulated by CK2 phosphorylation of cyclin H.
Schneider E; Kartarius S; Schuster N; Montenarh M
Oncogene; 2002 Aug; 21(33):5031-7. PubMed ID: 12140753
[TBL] [Abstract][Full Text] [Related]
14. Regulation of CAK kinase activity by p53.
Schneider E; Montenarh M; Wagner P
Oncogene; 1998 Nov; 17(21):2733-41. PubMed ID: 9840937
[TBL] [Abstract][Full Text] [Related]
15. p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner.
Ko LJ; Shieh SY; Chen X; Jayaraman L; Tamai K; Taya Y; Prives C; Pan ZQ
Mol Cell Biol; 1997 Dec; 17(12):7220-9. PubMed ID: 9372954
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.
Garrett S; Barton WA; Knights R; Jin P; Morgan DO; Fisher RP
Mol Cell Biol; 2001 Jan; 21(1):88-99. PubMed ID: 11113184
[TBL] [Abstract][Full Text] [Related]
17. Xenopus phospho-CDK7/cyclin H expressed in baculoviral-infected insect cells.
Lawrie AM; Tito P; Hernandez H; Brown NR; Robinson CV; Endicott JA; Noble ME; Johnson LN
Protein Expr Purif; 2001 Nov; 23(2):252-60. PubMed ID: 11676600
[TBL] [Abstract][Full Text] [Related]
18. Cdk-activating kinase complex is a component of human transcription factor TFIIH.
Shiekhattar R; Mermelstein F; Fisher RP; Drapkin R; Dynlacht B; Wessling HC; Morgan DO; Reinberg D
Nature; 1995 Mar; 374(6519):283-7. PubMed ID: 7533895
[TBL] [Abstract][Full Text] [Related]
19. The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II.
Cujec TP; Okamoto H; Fujinaga K; Meyer J; Chamberlin H; Morgan DO; Peterlin BM
Genes Dev; 1997 Oct; 11(20):2645-57. PubMed ID: 9334327
[TBL] [Abstract][Full Text] [Related]
20. Cyclin-dependent kinase inhibitor p16INK4A inhibits phosphorylation of RNA polymerase II by general transcription factor TFIIH.
Serizawa H
J Biol Chem; 1998 Mar; 273(10):5427-30. PubMed ID: 9488660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]